G1 Therapeutics Inc (NASDAQ:GTHX)
| 1.98 Delayed Data As of Dec 04 |  0.00 / 0.00%Today’s Change | 1.08 Today|||52-Week Range 8.40 | -63.54% Year-to-Date |
Latest GTHX News | Press Releases
No recent news for G1 Therapeutics Inc.
Today’s Trading
| Previous close | 2.00 |
| Today’s open | 2.00 |
| Day’s range | 1.93 - 2.11 |
| Volume | 872,655 |
| Average volume (3 months) | 718,236 |
| Market cap | $103.2M |
Data as of 3:59pm ET, 12/04/2023
Growth & Valuation
| Earnings growth (last year) | +4.37% |
| Earnings growth (this year) | +55.50% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | +62.98% |
| P/E ratio | NM |
| Price/Sales | 4.62 |
| Price/Book | 1.50 |
Competitors
| ---- | ||
| MISTMilestone Pharmaceut... | +0.22 | +6.94% |
| --W World Corp | 0.00 | 0.00% |
| CARMCarisma Therapeutics... | +0.16 | +6.48% |
Data as of 3:59pm ET, 12/04/2023
Financials
| Next reporting date | February 21, 2024 |
| EPS forecast (this quarter) | -$0.35 |
| Annual revenue (last year) | $51.3M |
| Annual profit (last year) | -$147.6M |
| Net profit margin | -287.63% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Research Triangle Park, North Carolina |
Forecasts
